Development and Validation of an RP-HPLC Method for Estimation of Tizanidine Hydrochloride in Pharmaceutical Dosage Forms

Authors

  • Ritika Saini
  • K. Nagarajan
  • Monika Kaurav
  • Surbhi Kamboj

Keywords:

Tizanidine hydrochloride, RP-HPLC method, precision, quantification etc

Abstract

Tizanidine hydrochloride is a central muscle relaxant that acts as an agonist for centrally activating alpha-2 adrenoreceptors. It works for the treatment of spasticity, which is a neurological condition. Therefore, along with the increasing use of this drug, its quantification in the pharmaceutical formulation becomes essential for the drug quality control and regulatory purposes. A common way to detect it is using the tizanidine hydrochloride assay using liquid chromatography. In this study, qualitative and quantitative analysis-based RP-HPLC method was developed and validated for the estimation of tizanidine hydrochloride.  The measurement of all tizanidine hydrochloride samples was performed on a C18 column, chromatographic separation was accomplished with an acetonitrile-phosphate buffer pH 7.5 (80:20 v/v) as the mobile phase at a flow rate of 1.5 mL/min during detection period. For detection purpose, use of UV detector was made at working wavelength of 230nm. The current procedure was verified in compliance with the ICH recommendations for a wide variety of parameters including specificity, linearity, precision, robustness and system suitability. The developed method shows suitable linearity at different concentration ranges with a correlation coefficient (R²) of 0.998. The precision was confirmed by low relative standard deviations (%RSD) for intra- and inter-day analyses. The robustness of the approach was evaluated through slight intentional changes in the chromatographic conditions which indicated no significant influence on the results. In conclusion, the suggested method using RP-HPLC is appropriate for routine evaluation of pharmaceutical formulations and bulk tizanidine hydrochloride because of its simplicity and precision.

Downloads

Download data is not yet available.

References

Araujo, P. (2009). Key aspects of analytical method validation and linearity evaluation. Journal of Chromatography B, 877(23), 2224–2234. https://doi.org/10.1016/j.jchromb.2008.09.030

Chandran, S., & Singh, R. S. P. (2007). Comparison of various international guidelines for analytical method validation. In Pharmazie (Vol. 62, Issue 1, pp. 4–14). https://doi.org/10.1691/ph.2007.1.5064

González, A. G., Herrador, M. Á., & Asuero, A. G. (2010). Intra-laboratory assessment of method accuracy (trueness and precision) by using validation standards. Talanta, 82(5), 1995–1998. https://doi.org/10.1016/j.talanta.2010.07.071

González, O., Blanco, M. E., Iriarte, G., Bartolomé, L., Maguregui, M. I., & Alonso, R. M. (2014). Bioanalytical chromatographic method validation according to current regulations, with a special focus on the non-well defined parameters limit of quantification, robustness and matrix effect. Journal of Chromatography A, 1353, 10–27. https://doi.org/10.1016/j.chroma.2014.03.077

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE VALIDATION OF ANALYTICAL PROCEDURES: TEXT AND METHODOLOGY Q2(R1). (n.d.).

John, P., Khan, I. U., Akkurt, M., Ramzan, M. S., & Sharif, S. (2011). 5-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine (tizanidine). Acta Crystallographica Section E: Structure Reports Online, 67(4). https://doi.org/10.1107/S1600536811008348

Kamen, L., Henney, H. R., & Runyan, J. D. (2008). A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury. Current Medical Research and Opinion, 24(2), 425–439. https://doi.org/10.1185/030079908X261113

Koyuncuǒglu, H., Ariciǒglu, F., Üresin, Y., Dizdar, Y., & Esin, Y. (1992). Effects of tizanidine on morphine physical dependence: Attenuation and intensification. Pharmacology Biochemistry and Behavior, 42(4), 693–698. https://doi.org/10.1016/0091-3057(92)90016-9

Kumar Bhardwaj, S. (2015). A Review: HPLC Method Development and Validation. http://www.urpjournals.com

Malanga, G., Reiter, R. D., & Garay, E. (2008a). Update on tizanidine for muscle spasticity and emerging indications. Expert Opinion on Pharmacotherapy, 9(12), 2209–2215. https://doi.org/10.1517/14656566.9.12.2209

Malanga, G., Reiter, R. D., & Garay, E. (2008b). Update on tizanidine for muscle spasticity and emerging indications. Expert Opinion on Pharmacotherapy, 9(12), 2209–2215. https://doi.org/10.1517/14656566.9.12.2209

Peris‐Vicente, J., Esteve‐Romero, J., & Carda‐Broch, S. (2015). Validation of Analytical Methods Based on Chromatographic Techniques: An Overview. In Analytical Separation Science (pp. 1757–1808). Wiley. https://doi.org/10.1002/9783527678129.assep064

Semenchuk, M. R., & Sherman, S. (2000). Effectiveness of tizanidine in neuropathic pain: An open-label study. Journal of Pain, 1(4), 285–292. https://doi.org/10.1054/jpai.2000.9435

Suresh, R., Anarthanan, S. V. J., Manavalan, R., & Valliappan, K. (2010). ASPECTS OF VALIDATION IN HPLC METHOD DEVELOPMENT FOR PHARMACEUTICAL ANALYSIS-COMPARISON OF VALIDATION REQUIREMENTS BY FDA, USP AND ICH. 1(12). www.ijpsr.com

Waghule, T., Narayan Saha, R., & Singhvi, G. (2021). UV spectroscopic method for estimation of temozolomide: Application in stability studies in simulated plasma pH, degradation rate kinetics, formulation design, and selection of dissolution media. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 258, 119848. https://doi.org/10.1016/j.saa.2021.119848

Zhu, L. L., Wang, Y. H., & Zhou, Q. (2024a). Tizanidine: Advances in Pharmacology & Therapeutics and Drug Formulations. In Journal of Pain Research (Vol. 17, pp. 1257–1271). Dove Medical Press Ltd. https://doi.org/10.2147/JPR.S461032

Zhu, L. L., Wang, Y. H., & Zhou, Q. (2024b). Tizanidine: Advances in Pharmacology & Therapeutics and Drug Formulations. In Journal of Pain Research (Vol. 17, pp. 1257–1271). Dove Medical Press Ltd. https://doi.org/10.2147/JPR.S461032

Downloads

Published

2025-06-24

How to Cite

1.
Saini R, Nagarajan K, Kaurav M, Kamboj S. Development and Validation of an RP-HPLC Method for Estimation of Tizanidine Hydrochloride in Pharmaceutical Dosage Forms. J Neonatal Surg [Internet]. 2025Jun.24 [cited 2025Nov.18];14(26S):1069-7. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/7648

Issue

Vol. 14 No. 26S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.